丙型肝炎病毒感染护理中的共定位：阿片类激动剂治疗诊所的作用。
Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics.
作者信息
Taylor Lynn E
机构信息
Research Professor University of Rhode Island Providence RI.
Director of HIV and Viral Hepatitis Services CODAC Behavioral Health Providence RI.
出版信息
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):12-15. doi: 10.1002/cld.921. eCollection 2020 Jul.
Abstract
Watch an interview with the author.
摘要
观看对作者的采访。
相似文献
1
Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics.丙型肝炎病毒感染护理中的共定位：阿片类激动剂治疗诊所的作用。
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):12-15. doi: 10.1002/cld.921. eCollection 2020 Jul.
2
Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.减少伤害覆盖范围与丙型肝炎发病率：来自注射毒品人群队列的研究结果
Am J Prev Med. 2020 Jun;58(6):845-853. doi: 10.1016/j.amepre.2020.01.024.
3
Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.阿片类激动剂治疗与年轻成年注射吸毒者丙型肝炎病毒感染发生率降低相关。
JAMA Intern Med. 2014 Dec;174(12):1974-81. doi: 10.1001/jamainternmed.2014.5416.
4
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study.澳大利亚悉尼阿片类激动剂治疗诊所中客户对丙型肝炎治疗启动的抵触情绪：一项定性研究。
Drug Alcohol Rev. 2022 Mar;41(3):706-714. doi: 10.1111/dar.13414. Epub 2021 Nov 28.
5
Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment.接受阿片类药物激动剂治疗的患者对丙型肝炎治疗的认知障碍。
J Addict Med. 2012 Sep;6(3):233-9. doi: 10.1097/ADM.0b013e31825f491b.
6
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.针对接受阿片类药物替代治疗的吸毒者及社区卫生诊所中的丙型肝炎病毒感染者的治疗：ETHOS研究。
Addiction. 2016 Feb;111(2):311-9. doi: 10.1111/add.13197. Epub 2015 Nov 25.
7
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).注射吸毒人群丙型肝炎病毒感染的综合治疗：一项随机对照试验的研究方案（INTRO-HCV）。
BMC Infect Dis. 2019 Nov 8;19(1):943. doi: 10.1186/s12879-019-4598-7.
8
Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.接受阿片类药物替代疗法人群中丙型肝炎病毒感染的流行病学研究（ECHO）：研究方案
BMC Infect Dis. 2015 Dec 10;15:563. doi: 10.1186/s12879-015-1307-z.
9
Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low-threshold primary health-care opioid agonist treatment program.在低门槛的初级卫生保健阿片类激动剂治疗方案中，直接作用抗病毒治疗丙型肝炎的依从性支持的可行性和可接受性。
Drug Alcohol Rev. 2019 Feb;38(2):185-189. doi: 10.1111/dar.12903. Epub 2019 Feb 13.
10
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.阿片类激动剂治疗剂量、患者感知的剂量充足性以及注射吸毒者丙型肝炎感染风险。
CMAJ. 2019 Apr 29;191(17):E462-E468. doi: 10.1503/cmaj.181506.
引用本文的文献
1
Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study.南非男性刑事司法涉案人员中阿片类药物使用和艾滋病毒治疗服务体验：一项定性研究。
Harm Reduct J. 2023 Jul 21;20(1):90. doi: 10.1186/s12954-023-00834-6.
2
Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.描述安大略省第一民族人群丙型肝炎病毒感染的关怀级联：一项回顾性队列研究。
CMAJ. 2023 Apr 11;195(14):E499-E512. doi: 10.1503/cmaj.220717.
本文引用的文献
1
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新：美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
2
Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis.直接作用抗病毒药物治疗注射吸毒或接受阿片类药物替代治疗的慢性丙型肝炎病毒感染者的疗效：系统评价和荟萃分析。
Clin Infect Dis. 2020 May 23;70(11):2355-2365. doi: 10.1093/cid/ciz696.
3
Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.在接受阿片类激动剂治疗的药物注射者中，直接作用抗病毒治疗后丙型肝炎再感染率较低。
Clin Infect Dis. 2020 Jun 10;70(12):2695-2702. doi: 10.1093/cid/ciz693.
4
Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review.注射吸毒且携带丙型肝炎病毒人群的综合关怀模式：系统评价。
Int J Drug Policy. 2019 Oct;72:146-159. doi: 10.1016/j.drugpo.2019.05.023. Epub 2019 May 27.
5
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.全球、区域和国家级别的注射吸毒对丙型肝炎病毒传播的贡献：一项建模研究。
Lancet Gastroenterol Hepatol. 2019 Jun;4(6):435-444. doi: 10.1016/S2468-1253(19)30085-8. Epub 2019 Apr 10.
6
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.波士顿社区健康中心中曾有过无家可归经历的个体的丙型肝炎治疗结果。
Int J Drug Policy. 2019 Oct;72:129-137. doi: 10.1016/j.drugpo.2019.03.017. Epub 2019 Apr 6.
7
Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment.直接作用抗病毒疗法治疗接受阿片类激动剂治疗或海洛因辅助治疗的丙型肝炎感染。
Int J Drug Policy. 2018 Dec;62:74-77. doi: 10.1016/j.drugpo.2018.10.003. Epub 2018 Oct 24.
8
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.澳大利亚注射吸毒人群中直接抗丙型肝炎病毒药物的快速使用与病毒血症流行率下降之间的关联。
J Hepatol. 2019 Jan;70(1):33-39. doi: 10.1016/j.jhep.2018.09.030. Epub 2018 Oct 25.
9
Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.美沙酮维持治疗的阿片类药物使用障碍患者丙型肝炎病毒管理的整合、共置、远程医疗治疗方法。
Clin Infect Dis. 2019 Jul 2;69(2):323-331. doi: 10.1093/cid/ciy899.
10
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis.直接作用抗病毒药物治疗丙型肝炎在药物使用者和注射毒品者中的应用：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2018 Nov;3(11):754-767. doi: 10.1016/S2468-1253(18)30304-2. Epub 2018 Sep 21.
Zotero 插件